Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The ...

Doctors and researchers at the University of Nebraska Medical Center are hoping to bring a different therapy that uses a ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

in that the new gene therapy gives hope. Even though it isn't appropriate for all people with sickle cell disorder, it "increases choice". New trial medications will continue to be licensed - and ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...

In a new study, researchers found that the inflammation behind painful episodes in sickle cell disease are correlated with ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL ...

Sickle cell conditions are genetic blood disorders that affect haemoglobin, the molecule in red blood cells responsible for ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

LINCOLN, Neb. (KOLN) - Groundbreaking advancements in Sickle Cell treatment are changing and saving lives nationwide. For decades, patients with Sickle Cell Disease have lived with pain ...